The complex epidemiology of extended-spectrum β-lactamase-producing Enterobacteriaceae-Reference-Cited by-同舟云学术

The complex epidemiology of extended-spectrum β-lactamase-producing Enterobacteriaceae

Published:2015-05 Issue:5 Volume:10 Page:819-839
ISSN:1746-0913
Container-title:Future Microbiology
language:en
Short-container-title:Future Microbiology

Author:

Tal Jasper Ruthy¹,Coyle Joseph R²,Katz David E³,Marchaim Dror¹⁴

Affiliation:

1. Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel

2. Division of Communicable Diseases, Bureau of Disease Control, Prevention & Epidemiology, Michigan Department of Community Health, 201 Townsend St, Lansing, MI, USA, 48909

3. Department of Internal Medicine D, Shaare Zedek Medical Center, Jerusalem, Israel

4. Division of Infectious Diseases, Assaf Harofeh Medical Center, Zerifin, Israel

Abstract

ABSTRACT Antimicrobial resistance is a growing worldwide iatrogenic complication of modern medical care. Extended-spectrum β-lactamases have emerged as one of the most successful resistance mechanisms, limiting our therapeutic options to treat various human infections. The dissemination of these enzymes to the community probably signifies an irreversible step. This paper will review the evolution of human infections associated with extended-spectrum β-lactamase-producing organisms in the past 20 years, and will present and discuss the current challenges, controversies, debates and knowledge gaps in this research field.

Publisher

Future Medicine Ltd

Subject

Microbiology (medical),Microbiology

Link

https://www.futuremedicine.com/doi/pdf/10.2217/fmb.15.16

Reference223 articles.

1. Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America

2. Has the era of untreatable infections arrived?

3. “Swimming in resistance”: Co-colonization with carbapenem-resistant Enterobacteriaceae and Acinetobacter baumannii or Pseudomonas aeruginosa

4. Urinary Tract Infections Caused by Multi-Drug Resistant Proteus mirabilis: Risk Factors and Clinical Outcomes

5. Proteus mirabilis Bloodstream Infections: Risk Factors and Treatment Outcome Related to the Expression of Extended-Spectrum β-Lactamases

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High oral carriage of multidrug resistant Gram-negative bacilli in adolescents: the SOPKARD-Junior study;Frontiers in Cellular and Infection Microbiology;2023-11-16

2. The Impact of COVID-19 Pandemic on ESBL-Producing Enterobacterales Infections: A Scoping Review;Antibiotics;2023-06-16

3. Systematic Review and Meta-analysis on Extended-Spectrum β-lactamases Producing Klebsiella pneumoniae in Nepal;Microbiology Insights;2023-01

4. Epidemiology of extended-spectrum beta-lactamase producing Enterobacteriaceae in Qatar: A 3-year hospital-based study;Frontiers in Antibiotics;2022-09-07

5. Treatment and Epidemiology of Third-Generation Cephalosporin-Resistant Urinary Tract Infections;Pediatrics;2022-06-23